Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
41.3K
-
Shares change
-
-1.9K
-
Total reported value, excl. options
-
$140K
-
Value change
-
-$14.6K
-
Number of buys
-
2
-
Number of sells
-
-3
-
Price
-
$3.36
Significant Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q4 2015
7 filings reported holding VKTX - Viking Therapeutics, Inc. - COMMON STOCK as of Q4 2015.
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.3K shares
of 112M outstanding shares and own 0.04% of the company stock.
Largest 8 shareholders include VANGUARD GROUP INC (18.9K shares), GOLDMAN SACHS GROUP INC (12.8K shares), WELLS FARGO & COMPANY/MN (6.25K shares), Creative Planning (3K shares), BlackRock Investment Management, LLC (327 shares), UBS Group AG (0 shares), Tower Research Capital LLC (TRC) (0 shares), and ROYAL BANK OF CANADA (3.13K shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.